2026-10-23

wangvc Inflection Daily · 2026-10-23

3m 00s · English narration

Today in three sentences

  1. Gold closed at $4000.46 (10-23), down 27.4% from its 250-day high of $5510.73 and needing a 37.8% gain to get back there; it hit an intraday low of $3987, a new low since July — safe-haven demand is receding.
  2. The CCC tier (borrowers closest to default) spread rose to 13.40%, and the CCC−BB tiering gap widened to 1130bp, both new highs for this cycle (10-22), while the high-yield composite spread remains at just 3.40% — the market isn't tightening broadly, it's only repricing the weakest tier.
  3. Bitcoin spot ETFs saw net outflows of $636M on 10-22, turning October's cumulative flow negative at -$175M, running counter to the on-chain "realized-cap slope in accumulation mode" reading (score +0.85, 10-23).

Main thread: AI buildout → cost of capital (Day 27, since 09-27) · Today's change: the 10-year yield rose back to 4.986% (10-23), while the CCC-tier spread set another new high at 13.40% the day before (10-22) — both ends of the chain tightening at once

Change from yesterday: yesterday was a divergence of "rates falling, weak credit widening"; today the rate side turned up too (rising about 3bp to 4.986%), while the weak-credit side stepped up another notch (CCC−BB at 1130bp, 10-22) — the first time both ends moved the same direction. The leading signals haven't backed off: power CPI YoY at 4.37%, commercial power PPI YoY at 4.15% (September, FRED); hyperscalers filed 6 additional 424B prospectus supplements (SEC filings required before issuing debt) in the past 90 days. The chain is still biting its own tail: building requires borrowing, borrowing pushes up the long end, building drives up power prices, power prices feed into inflation, and the Fed becomes even less willing to cut — the real rate (the 10-year TIPS yield, i.e., the true cost of borrowing after stripping out inflation) is stuck high at 2.76% (10-21). Counterpoint: AI spending is largely counted as capital investment and doesn't flow directly into CPI, and the rise in power prices is somewhat regional — but rate pricing is driven by the here-and-now and the margin.

Recheck: 1 power CPI at 4.37% remains above headline inflation — the cost side hasn't eased; 2 financing is still happening — Broadcom agreed to lend Anthropic up to $42bn to lease its own chips (10-01), covering nearly a third of a $125.2bn TPU lease, with the "Polaris" SPV (a shell entity set up for a single financing, ring-fenced from the parent's risk) subordinated tranche yielding over 10% (10-16); 3 both pricing-side metrics worsened together: the 10-year at 4.986% and CCC−BB at 1130bp. Invalidation conditions (either one triggers a thread switch): 10-year TIPS falling back below 2.50% with CCC−BB narrowing to within 900bp; or the five hyperscalers' median YoY capex dropping from 100.1% to below 50% with 424B debt issuance at zero for 90 straight days. Neither triggered today.

Private credit's three lights

3/3 lit, same as yesterday, the third light brighter. 1 BDC (publicly listed private credit funds, where a share price below NAV means a discount) basket median discount -15.3%, median drawdown -17.3% (10-23; NAV still from the 6-30 quarterly report); 2 semi-liquid fund exits are queuing: Blue Owl OCIC/OTIC Q3 redemption requests at 16.8%/39% of shares, allotted under the 5% cap; KKR K-FITS invoked the 2% elasticity clause for 100% payout; Apollo/Ares secondary tender discounts at 13-15% (as of 10-19); 3 CCC−BB at 1130bp, a new high for this cycle (10-22). Three independent sources point to the same thing: the public-market composite spread is only 3.40% — risk has moved to places without daily pricing, and discounts and redemption queues are the real price.

Twelve domains

AI — Chip stocks rebounded but haven't recovered: AMD +1.96%, Micron +3.17%, Nvidia -0.24%, with monthly losses still steep (AMD -16.7%, Micron -19.7%, Super Micro -21.1%, all as of 10-23).

BTC — Current price around $81.5k (10-23), with mixed technicals: the 4-hour RSI at 44.6 and the daily at 47.3 lean bearish, while the weekly at 56.6 leans bullish. Strategy added 267 BTC between 10-12 and 10-18, for a total of 848,517 BTC (SEC 8-K); Section 4's three conditions are 2/3 met, the macro regime check is 1/4.

Gold — After dipping below 4000, gold recovered to $4000.46, down 4.4% over 5 days, breaking down from a three-week 4066-4227 consolidation range. The pressure comes from elevated real rates (10-year TIPS at 2.76%, 10-21). Medium-term support is unchanged: global gold ETFs added 67 tonnes in September to a record 4256 tonnes, with China adding 23 tonnes in September to 2410 tonnes, marking 23 straight months of net buying.

A-share — The STAR 50 closed at 1345.51, up 3.04%, with 8 related ETFs broadly up 3.0%-4.3%, though still down 17%-27.5% over the past month; the anomaly is in breadth — only 7 of 50 constituents are above their 200-day average, meaning the rebound is concentrated in a handful of names. Domestic equipment's share of domestic wafer fabs rose from 16% to 21% (Bernstein, reported 10-17).

Bonds — 10-year at 4.986% (10-23); MOVE (Treasury volatility index, higher means more bond-market unease) at 102.71, still up 30.7% for the month. The 20-year auction's indirect bidding fell to 58.2% on 10-21 — overseas demand is weakening. Anomaly: 5y5y forward inflation expectations (the market's expected inflation for the five years starting five years out) plunged from 2.34 to 2.19 in a single day on 10-22, needs confirmation on the next trading day.

Congress — Low temperature, no anomaly. MSFT leads the Sentinel score at 13 (5 filings, 4 members of Congress over the past 30 days), and reports fiscal Q1 earnings on 10-28. The Senate's anti-insider-trading bill motion fell short of the 60-vote threshold at 53:47 on 9-30, essentially zeroing out the odds of legislation this year.

Biotech — XBI closed at $151.64 on 10-22, down 10.6% from its 8-19 high — weakness tracking risk appetite, not deteriorating fundamentals. China's out-licensing of innovative drugs has reached $139.4bn YTD, already above full-year 2025's $138.8bn (Reuters, 10-16). Anomaly: cell therapy's Ph1-to-Ph3 conversion rate is just 2.1% (433 → 9 programs), far below monoclonal antibodies' 58.4% (10-23).

Cybersecurity — A-shares staged a limit-up-style rebound: NSFOCUS +19.98%, Venustech hit the +10% limit, Sangfor +12.85% (10-23). The catalyst was the Cyberspace Administration's 15th Five-Year Plan giving cybersecurity its own standalone section, plus the leak of the core PHP vulnerability "PHP2Shell" (CVSS 9.2, a severity score out of 10). But three extreme reversals within 10 days is itself an anomaly; whether it holds depends on Fortinet's 10-28 earnings and Q3 reports from 10-29 to 10-31.

Energy — Henry Hub natural gas front-month at $2.644, down a sharp 17.68% for the week, easing the cost side for power prices; in the same week Brent rose 10.36% and WTI rose 7.46% — the oil-gas divergence is today's most notable anomaly. Grid equipment's YTD median return leads the solar/storage manufacturing segment by 65.6 points, and it stabilized on 10-23. Storage orders over the past 90 days: 11 deals, 16.54GWh of independent demand, zero from related parties.

Emerging — CIBR at $105.96, up 3.06% on the day and +47.2% YTD; BLOK down 7.0% YTD and -19.2% over the past month (10-23). The FSB Secretary-General warned on 10-21 that concentration in AI models and cloud providers poses systemic risk — the AWS and Google Cloud outages from 10-20 to 22 just gave a live example.

Venture — Global VC in 26Q3 fell back to $159bn, with the US at $98.4bn (MoM -40%); AI's share has cooled for three straight quarters (80% → 70% → 64%). Anthropic is reportedly planning a November IPO, with valuation discussions revised down from $2 trillion to about $1.5 trillion (10-15); as of 10-23, no S-1 has appeared on SEC EDGAR. Anomaly: of six tracked names, only Fermi (FRMI) at $2.5923 hit a new post-IPO low (-48.46% for the month), while the other five rebounded in tandem.

Winners — Zhipu (HKEX:2513) closed at HK$499, up 6.82% (-33.82% over the past month); MiniMax (HKEX:100) closed at HK$187.6, up 12.14% (-35.31% over the past month). The catalyst is clear: MiniMax open-sourced M3.1 Flash (10-23), cutting inference costs by about 70% and lifting the Hang Seng Tech Index roughly 2.05%.

Cross-dashboard links

Signals worth watching next

  1. 10-28 FOMC and Microsoft/Alphabet capex guidance: If guidance is raised while the CCC spread stays >13%, the main thread strengthens; if median YoY capex guidance drops below 50% and CCC−BB narrows to within 900bp, that's the first piece of counter-evidence for a thread switch.
  2. 2-year, 5-year, and 7-year auctions on 10-27 / 10-28 / 10-30: Watch whether indirect bidding stays below 58.2%; combined with the 10-29 core PCE print, this determines whether the real rate stays above 2.7%.
  3. Two readings awaiting confirmation: Whether 5y5y forward inflation at 2.19 recovers back above 2.30; whether bitcoin spot ETFs post net outflows over $500M for two straight days (if so, the on-chain accumulation signal is invalidated).
This page compiles and analyzes publicly available information,Not investment advice; see methodology, sources, and disclaimer atTerms of Use。